Heinrich Henriette, Bauerfeind Peter
Department of Hepatology and Gastroenterology, University of Züerich, Züerich, Switzerland.
Recent Results Cancer Res. 2010;182:85-91. doi: 10.1007/978-3-540-70579-6_7.
Minamally invasive endoscopic resection techniques allow definitive histological staging for dysplasia and early cancer and in many cases curative treatment. In Barrett's esophagus with High Grade Dysplasia (HGD) or early mucosal cancer, endoscopic mucosal resection (EMR) should be considered both as diagnostic and therapeutic first line procedure, with the possibility to repeat the procedure in case of residual Barrett's dysplasia or mucosal cancer. In early cancer of the the submucosa, surgical resection should be discussed. Endoscopic submucosal dissection (ESD) is a useful therapeutic option for HGD or early cancer in the squamous epithelium of the esophagus or in the stomach when en bloc resection is needed in large lesions.
微创内镜切除技术可为发育异常和早期癌症提供确切的组织学分期,并且在许多情况下可实现治愈性治疗。在患有高级别发育异常(HGD)或早期黏膜癌的巴雷特食管中,内镜黏膜切除术(EMR)应被视为诊断和治疗的一线程序,若存在残留的巴雷特发育异常或黏膜癌,有可能重复该程序。对于早期黏膜下癌,应讨论手术切除。当需要对大病变进行整块切除时,内镜黏膜下剥离术(ESD)是食管或胃鳞状上皮中HGD或早期癌症的一种有用的治疗选择。